Arkolith/Insider Trading/VYNE/Form 4

Domzalski David

PRESIDENT AND CEO, DirectorVYNE Therapeutics Inc. (VYNE) · full profile →Form 4 · filed Jan 2, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 31, 2024Tax withholding(F)25K$3.35$82K476K

Transaction Codes

F
Shares withheld for taxes

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-25-000152) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML